Trends in microvascular research. The microembolism syndrome.
D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D001344:Autopsy; D001779:Blood Coagulation Factors; D004285:Dogs; D005337:Fibrin; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000097:blood; D006333:Heart Failure / Q000097:blood; D006801:Humans; D000860:Hypoxia / Q000097:blood; D007668:Kidney / Q000503:physiopathology; D008168:Lung / Q000098:blood supply / Q000473:pathology*; D008196:Lymph / Q000378:metabolism; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors; D015849:Plasminogen Inactivators; D011453:Prostaglandins / Q000378:metabolism; D011655:Pulmonary Embolism / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D011667:Pulmonary Veins / Q000473:pathology; D012119:Respiration / Q000187:drug effects; D012131:Respiratory Insufficiency / Q000209:etiology; D013577:Syndrome; D013917:Thrombin / Q000494:pharmacology; D014947:Wounds and Injuries / Q000150:complications
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D015849:Plasminogen Inactivators; D011453:Prostaglandins; D005337:Fibrin; D010960:Plasminogen Activators; D013917:Thrombin